glp-1 supply tracker Ro launches to help patients navigate shortages GLP-1 Medication Tracker: Weight Loss,

ENACT: A protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

Anti-Aging Therapy By optimizing or introducing targeted compounds, patients may experience improved vitality and solutions for specific issues like chronic fatigue, weight management challenges, or diminished skin elasticity

And a quick note on safety: if you're immunocompromised, have a central line, or have significant chronic illness, discuss probiotics with your clinician first

This is a distinct product from Rybelsus (oral semaglutide 7mg/14mg), which remains licensed for type 2 diabetes mellitus only and is not indicated for weight management in other patients, a distinction that pharmacists should be clear on when counselling patients who may confuse the two 11